Christopher Rovaldi, SVP, Program Management and Operations at ACCELERON PHARMA INC (XLRN), sold 14,000 shares at $38.32 ($538K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Open-market sale of $538k XLRN by SVP, Program Management and Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.32 | 12,735 | $488K | 90.7% |
| 2 | $39.30 | 1,165 | $46K | 8.5% |
| 3 | $39.96 | 100 | $4K | 0.7% |
| Total | $38.41 avg | 14,000 | $538K | 100% |
| Filing → |
| XLRN | SELL | 2018-04-04 | $245K | — | Filing → |
| XLRN | SELL | 2018-01-17 | $495K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $157K | — | Filing → |